BioCentury
ARTICLE | Product Development

Treating HAE

November 1, 2004 8:00 AM UTC

In normal patients, C1 esterase inhibitor can normalize inflammation by intervening to slow formation of prekallikrien from Factor XIIa or by inhibiting conversion of HMW-kininogen. Kallikrein mediate...